Immucell Corp.
ICCC
Market Cap$39.14M
Close$
$6.58
30.6% upside
Current Fair Value
30.6% upsideUndervalued by 30.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.14 Million |
|---|---|
| Enterprise Value | $50.13 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.75 |
| Beta | 0.13 |
| Outstanding Shares | 7,750,864 |
| Avg 30 Day Volume | 8,645 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.78 |
|---|---|
| PEG | 21.41 |
| Price to Sales | 2.52 |
| Price to Book Ratio | 1.68 |
| Enterprise Value to Revenue | 2.87 |
| Enterprise Value to EBIT | -8.72 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
ESG Score
No data
About Immucell Corp.
CEO: Michael Brigham